Zyani A, Elyachioui K, Treyi C, Aabdi M, Sbai H
Anesthesiology and Intensive Care Unit, Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, Tangier, Morocco.
Ann Med Surg (Lond). 2021 Dec;72:103070. doi: 10.1016/j.amsu.2021.103070. Epub 2021 Nov 20.
Heparin-induced thrombocytopenia is a rare complication of heparin therapy associated with thrombocytopenia and mainly thrombotic complications.
we herein describe a case of a woman hospitalized for management of a severe case of COVID-19 treated with low molecular weight heparin, who developed heparin-induced thrombocytopenia complicated by intracerebral hemorrhage with no thrombotic complications.
Discontinuation of heparin was effective without the use of other non-heparin anticoagulants, platelet transfusion or plasmapheresis.
肝素诱导的血小板减少症是肝素治疗的一种罕见并发症,与血小板减少症相关,主要为血栓形成并发症。
我们在此描述一例因严重新型冠状病毒肺炎住院并接受低分子量肝素治疗的女性病例,该患者发生了肝素诱导的血小板减少症,并并发脑出血,无血栓形成并发症。
停用肝素有效,无需使用其他非肝素抗凝剂、血小板输注或血浆置换。